[Clinical experiences with the tuberculostatic drug capreomycin].
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001798:Blood Proteins / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D004352:Drug Resistance, Microbial; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D012830:Silicotuberculosis / Q000188:drug therapy* / Q000201:enzymology; D013183:Sputum / Q000382:microbiology; D000637:Transaminases / Q000097:blood
D000995:Antitubercular Agents; D001798:Blood Proteins; D000637:Transaminases; D000469:Alkaline Phosphatase
Klinische Erfahrungen mit dem Tuberkulostaticum Capreomycin.